Getting the Timing Right: Controlling BCL-2 Inhibition as an Anti-Fibrotic Therapy

Am J Respir Cell Mol Biol. 2024 Jan 23. doi: 10.1165/rcmb.2023-0436ED. Online ahead of print.NO ABSTRACTPMID:38259233 | DOI:10.1165/rcmb.2023-0436ED

Source: American Journal of Respiratory Cell and Molecular Biology - January 23, 2024 Category: Molecular Biology Authors: Joseph C Cooley Elizabeth F Redente Source Type: research